Tag: government

We explore how the key talking points from the Labour Party Annual Conference 2024 could impact the brain tumour community.

We’ve taken a close look at the pledges made in the Labour Party manifesto and what they could mean for people affected by a brain tumour.

We’ve taken a close look at the pledges made in the Conservative manifesto and what they could mean for people affected by a brain tumour.

Add your voice to ours by signing the Parliamentary Petition calling for the Government to urgently invest in establishing the UK as a world-beating force in cancer survival and care.

Our CEO, Sarah Lindsell, responds to The Government’s recent announcement regarding funding for the Charity sector during the coronavirus (COVID-19) pandemic.

With just over a month until Brexit, the Government are steadfastly working to ensure the UK secures a suitable deal with the EU

On the 23rd June 2016 the UK voted to leave the European Union (EU). We do not yet know how this will affect the brain tumour community.

The report follows a debate about funding for brain tumour research in the House of Commons on April 18.

Yesterday saw the Petitions Committee report on research funding into brain tumours debated by MP’s in Westminster Hall. Over 40 MPs spoke at the debate, with only standing room left as proceedings began.

A call for government action to prioritise brain tumour awareness and research funding will be debated in the House of Commons on April 18.

The e-petition calls on larger cancer charities and the government to invest more in research into brain tumours.

On Wednesday 9th December the All Party Parliamentary Group (APPG) on Brain Tumours held a meeting in Westminster to discuss the new five year Independent Cancer Taskforce Strategy. The event was well attended and several MPs came along to listen to the experiences and concerns of our supporters.

We would like to invite you to our meeting of the All-Party Parliamentary Group (APPG) on Brain Tumours.

The Off-patent Drugs Bill has been blocked at its second reading in the House of Commons despite support from MPs of both parties and a number of charities and health organisations. It will be put onto the agenda for another reading in December, however is unlikely to be allocated time for debate.

The potential benefit of the Off-patent Drugs Bill to people affected by a brain tumour has been highlighted in an editorial featured in The Telegraph. The paper also features a letter in support of The Bill signed by 40 clinicians including Professor Susan Short who is leading a clinical trial to investigate the effect of hydroxychloroquine on high grade gliomas undergoing radiotherapy.